Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

8.21
Delayed Data
As of Dec 02
 +0.29 / +3.66%
Today’s Change
2.38
Today|||52-Week Range
8.30
+94.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues35.4M43.0M43.2M39.3M
 
 
 
 
 
Cost of Goods Sold5.3M5.4M5.2M8.4M
 
 
 
 
 
Depreciation And Amortization386.0K419.0K251.0K475.0K
 
 
 
 
 
 
Operating ExpensesGross Income29.8M37.2M37.8M30.4M
 
 
 
 
 
General Expenses51.3M57.2M60.1M54.4M
 
 
 
 
 
Research And Development41.4M48.8M49.5M46.6M
 
 
 
 
 
Total Operating Expenses57.0M63.1M65.5M63.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.5M-20.0M-22.3M-24.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.7M
 
 
Interest Expense On Debt2.7M2.7M2.8M3.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.2M-22.7M-25.0M-28.6M
 
 
 
 
 
Net Income-24.2M-22.7M-25.0M-28.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS142.8M143.3M143.5M145.1M
 
 
 
 
 
Shares To Calculate EPS Diluted142.8M143.3M143.5M145.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.16-$0.17-$0.20
 
 
 
 
 
EPS Diluted-$0.17-$0.16-$0.17-$0.20